The level of clusterin expression in renal cancer cells was found to be closely associated with pathological stage and grade of the tumor, and the overall survival rate of patients with high clusterin expression was obviously lower than that of patients with weak expression [18]. The gene discussed is CLU; the disease is renal carcinoma.